This approach aims to optimize imagingwindows and improve diagnostic accuracy, advancing the translationalpotential of 64Cu-NOTA-Trodelvy-F­(ab’)2 for high-mortality cancers with pressing diagnostic gaps and strongclinical relevance for Trop2-targeted therapy. Here, TACSTD2 is linked to cancer.